Cargando…
Recombinant Human Clusterin Seals Damage to the Ocular Surface Barrier in a Mouse Model of Ophthalmic Preservative-Induced Epitheliopathy
There is a significant unmet need for therapeutics to treat ocular surface barrier damage, also called epitheliopathy, due to dry eye and related diseases. We recently reported that the natural tear glycoprotein CLU (clusterin), a molecular chaperone and matrix metalloproteinase inhibitor, seals and...
Autores principales: | Chintala, Shravan K., Pan, Jinhong, Satapathy, Sandeep, Condruti, Rebecca, Hao, Zixuan, Liu, Pei-wen, O’Conner, Christian F., Barr, Joseph T., Wilson, Mark R., Jeong, Shinwu, Fini, M. Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861099/ https://www.ncbi.nlm.nih.gov/pubmed/36674497 http://dx.doi.org/10.3390/ijms24020981 |
Ejemplares similares
-
Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye
por: Bauskar, Aditi, et al.
Publicado: (2015) -
Dynasore protects the ocular surface against damaging oxidative stress
por: Webster, Andrew, et al.
Publicado: (2018) -
Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye
por: Fini, M. Elizabeth, et al.
Publicado: (2020) -
Rapid high-yield expression and purification of fully post-translationally modified recombinant clusterin and mutants
por: Satapathy, Sandeep, et al.
Publicado: (2020) -
Epithéliopathie rétinienne diffuse
por: Abaloun, Yassine, et al.
Publicado: (2017)